STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
0 hedge funds and large institutions have $0 invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 31 closing their positions.
Holders
–
Holders Change
-31
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
31
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| – | – | -7,932 | Closed |
|
27
Citadel Advisors
Miami,
Florida
| – | – | -5,397 | Closed |
|
28
UBS Group
Zurich,
Switzerland
| – | – | -1,815 | Closed |
|
29
Group One Trading
Chicago,
Illinois
| – | – | -445 | Closed |
|
30
Wells Fargo
San Francisco,
California
| – | – | -185 | Closed |
|
31
Citigroup
New York
| – | – | -8 | Closed |
|
32
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | – | – |
|
|
VFA
33
Values First Advisors
Gray,
Tennessee
| – | – | – | – |
|
|
CFGS
34
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|